Impact of Steady State Cobicistat and Darunavir/Cobicistat on the Pharmacokinetics and Pharmacodynamics of Oral Anticoagulants (Rivaroxaban, Apixaban) in Health Volunteers

NCT03864406 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

NIH

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Cobicistat
DRUG: Darunavir/Cobicistat
DRUG: Rivaroxaban

Sponsor

National Institutes of Health Clinical Center (CC)